ATE230262T1 - Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung - Google Patents

Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung

Info

Publication number
ATE230262T1
ATE230262T1 AT96939912T AT96939912T ATE230262T1 AT E230262 T1 ATE230262 T1 AT E230262T1 AT 96939912 T AT96939912 T AT 96939912T AT 96939912 T AT96939912 T AT 96939912T AT E230262 T1 ATE230262 T1 AT E230262T1
Authority
AT
Austria
Prior art keywords
pct
emulsions
lipide
hydrolysis
optimized
Prior art date
Application number
AT96939912T
Other languages
English (en)
Inventor
German Pscherer
Marco Junginger
Joerg Nehne
Yvon A Carpentier
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7778601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE230262(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Application granted granted Critical
Publication of ATE230262T1 publication Critical patent/ATE230262T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96939912T 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung ATE230262T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19544310 1995-11-28
PCT/EP1996/005184 WO1997019683A1 (en) 1995-11-28 1996-11-23 Hydrolysis-optimized lipid emulsions and use thereof

Publications (1)

Publication Number Publication Date
ATE230262T1 true ATE230262T1 (de) 2003-01-15

Family

ID=7778601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939912T ATE230262T1 (de) 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung

Country Status (15)

Country Link
US (1) US6008248A (de)
EP (1) EP0863754B2 (de)
JP (1) JP4165904B2 (de)
CN (1) CN1259908C (de)
AT (1) ATE230262T1 (de)
AU (1) AU701736B2 (de)
BR (1) BR9611826A (de)
CA (1) CA2236422C (de)
CZ (1) CZ161898A3 (de)
DE (2) DE19648566A1 (de)
ES (1) ES2189891T5 (de)
MX (1) MX9804127A (de)
NZ (1) NZ322927A (de)
PL (1) PL186618B1 (de)
WO (1) WO1997019683A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090636A1 (de) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. Diät mit hohem Lipidgehalt
US6946488B2 (en) * 2000-05-01 2005-09-20 The Iams Company Pet food composition for reducing inflammatory response in cats
EP1539104A4 (de) * 2000-12-29 2005-06-15 Univ Columbia Verwendung von iv-emulsionen mit unterschiedlicher triglycerid-zusammensetzung, teilchengrösse und apolipoprotein e für die gezielte gewebeabgabe von hydrophoben verbindungen
JP5026655B2 (ja) * 2001-04-18 2012-09-12 プロメティック、バイオサイエンシーズ、インコーポレーテッド 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
EP1279400A1 (de) * 2001-07-25 2003-01-29 Target Hit sa Änderung der Fettsäurezusammensetzung Organ- und Gewebe-Zellmembranen
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
WO2003055323A1 (en) * 2001-12-27 2003-07-10 Genesis Group Inc. Seal oil based lipid emulsions and uses thereof
US8017170B2 (en) * 2002-08-29 2011-09-13 University Of Massachusetts Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
WO2011133841A2 (en) * 2010-04-23 2011-10-27 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Intravenous omega-3 fatty acid compositions & method of use
CN106241871A (zh) * 2016-07-15 2016-12-21 攀钢集团攀枝花钢铁研究院有限公司 高浓度钒液酸性铵盐沉钒方法
JP7370317B2 (ja) 2017-08-10 2023-10-27 ザ チルドレンズ メディカル センター コーポレーション 魚油および／またはオメガ３脂肪酸を含むエマルジョンに関する方法および組成物
CN108498562B (zh) * 2018-04-08 2021-03-16 北京壹诺药业有限公司 具有抗疲劳抗肿瘤增强免疫的油脂乳状液及其应用
WO2020072499A1 (en) * 2018-10-01 2020-04-09 M43 Ventures, Llc Ultrapure phenol compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
FR2618332B1 (fr) * 1987-07-23 1990-04-27 Synthelabo Emulsion lipidique destinee a la nutrition parenterale ou enterale
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response

Also Published As

Publication number Publication date
DE69625616D1 (de) 2003-02-06
DE19648566A1 (de) 1997-06-05
EP0863754B1 (de) 2003-01-02
DE69625616T2 (de) 2003-11-06
US6008248A (en) 1999-12-28
CZ161898A3 (cs) 1998-11-11
JP2000500769A (ja) 2000-01-25
BR9611826A (pt) 1999-07-13
EP0863754B2 (de) 2009-12-30
CN1202823A (zh) 1998-12-23
AU7697296A (en) 1997-06-19
CA2236422C (en) 2002-11-19
AU701736B2 (en) 1999-02-04
NZ322927A (en) 1999-06-29
PL326929A1 (en) 1998-11-09
DE69625616T3 (de) 2010-07-08
CN1259908C (zh) 2006-06-21
EP0863754A1 (de) 1998-09-16
JP4165904B2 (ja) 2008-10-15
ES2189891T3 (es) 2003-07-16
PL186618B1 (pl) 2004-02-27
CA2236422A1 (en) 1997-06-05
ES2189891T5 (es) 2010-04-27
WO1997019683A1 (en) 1997-06-05
MX9804127A (es) 1998-12-31

Similar Documents

Publication Publication Date Title
ATE230262T1 (de) Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung
ES2116530T3 (es) Productos de cuidado personal que contienen silicona.
IT8521644A0 (it) Succinimmidi modificati particolarmente per additivi usati come disperdenti per oli lubrificanti e benzine.
BR0008177A (pt) Ëleos com comprimentos de cadeia heterogêneos
BR9609816A (pt) Processo enzimático para redução de viscosidade de óleos vegetais com fosfolipase de aspergillus
DK0797432T3 (da) Olie-i-vand-emulsioner
CA2413105A1 (en) Recommending search terms using collaborative filtering and web spidering
ATE275932T1 (de) Verwendung bestimmter polyalkoxy compolymere für die behandlung von schuppen
BR9909502A (pt) Processo para redução do teor de componentes contendo fósforo em um óleo edìvel
KR950702231A (ko) 오일 첨가제 및 조성물(oil additives and compositions)
BR9509269A (pt) Processo para tratar diabetes
NO20001241L (no) Vandige emulsjoner av Fischer-Tropsch-væsker
KR950702223A (ko) 오일 첨가제 및 조성물(oil additives and compositions)
GR3032393T3 (en) Deoxygenation of an oil product with a laccase
FI963289A0 (fi) Öljykoostumukset
FR2748730B3 (fr) Receptacle a dimensions variables
AR000928A1 (es) Método para obtener plantas transgenicas
ITRM920586A0 (it) Macchina e procedimento per la produzione di olio di oliva senza frangitura dei noccioli.
EA199800624A1 (ru) Жир со специфическим противосклеротическим воздействием
Ruenkaew Marriage migration of Thai women to Germany
PT837775E (pt) Metodo para a producao de um laminado de embalagem com propriedades de barreira
SE9402454D0 (sv) Oil-in-water emulsions
Dhileepkumar et al. PAH Marks the Spot: Digging for Buried Clusters in Nearby Star-forming Galaxies-Ages and Extinctions for Embedded Clusters
Higginbotham et al. Internal slcerostomy with the Nd: YAG contact laser versus thermal sclerostomy in cynomolgus monkeys
AT5041U2 (de) Lipidhältige augentropfen als tränenersatzmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties